LivaNova (FRA:LIA) ROE % Adjusted to Book Value : 9.16% (As of Dec. 2024)

View and export this data going back to 2000. Start your Free Trial

What is LivaNova ROE % Adjusted to Book Value?

LivaNova's ROE % for the quarter that ended in Dec. 2024 was 17.49%. LivaNova's PB Ratio for the quarter that ended in Dec. 2024 was 1.91. LivaNova's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was 9.16%.

LivaNova ROE % Adjusted to Book Value Historical Data

The historical data trend for LivaNova's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LivaNova ROE % Adjusted to Book Value Chart

LivaNova Annual Data

Trend

Apr15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-9.23

-3.28

-2.94

0.65

2.60

LivaNova Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															2.40	-5.47	2.24	4.77	9.16

Competitive Comparison of LivaNova's ROE % Adjusted to Book Value

For the Medical Devices subindustry, LivaNova's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LivaNova's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, LivaNova's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where LivaNova's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

LivaNova ROE % Adjusted to Book Value Calculation

LivaNova's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	4.97%	/	1.91
	=	2.60%

LivaNova's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	17.49%	/	1.91
	=	9.16%

LivaNova ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of LivaNova's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

LivaNova Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » LivaNova PLC (FRA:LIA) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

LIVN:USA

Address

20 Eastbourne Terrace, London, GBR, W2 6LG

Website

https://www.livanova.com

UK-based LivaNova was born of a combination between Cyberonics in the us and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management and heart valve businesses. It derives roughly half of its revenue from the us market, another 21% from Europe, and the remainder from the rest of the world.

LivaNova Headlines

No Headlines